Ipca Laboratories Ltd. · Q3FY23
Result on 14 Feb 2023, first traded on 15 Feb 2023; judged on 13 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →
unreadverdict
—the read
-2.2%vs market, 10 sessions
+1.6%T+1
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
Close before₹849.15the base every move below is measured from
T+1+1.6%
T+10-4.9%market -2.7% · sector -4.0%
vs market-2.2%vs sector -0.9%
Best close after+1.6%traded as high as +2.3% on 16 Feb
Worst close after-5.1%traded as low as -5.8% on 24 Feb
Run-up, 30 sessions+1.5%into the result
52-week range21% below high1% above low
- Delivery share
- -0.5 points in the fortnight before, against the month before that
- Volume
- 1.08× its prior month, in the fortnight before
- Habit held
- unknown — could not be checked
- Announced
- Wed, after the close — the reaction session is the next day
- Peers reporting
- 2 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base | NIFTY PHARMA from base |
|---|---|---|---|---|---|---|---|---|---|
| T-29 | 3 Jan | 832.00 | 857.60 | 832.00 | 849.95 | — | +0.09% | +1.69% | +3.21% |
| T-28 | 4 Jan | 849.95 | 860.00 | 847.90 | 855.75 | +0.68% | +0.78% | +0.63% | +3.05% |
| T-27 | 5 Jan | 855.70 | 863.85 | 850.65 | 858.35 | +0.30% | +1.08% | +0.35% | +4.12% |
| T-26 | 6 Jan | 858.35 | 863.95 | 844.40 | 854.40 | -0.46% | +0.62% | -0.39% | +3.32% |
| T-25 | 9 Jan | 859.00 | 876.50 | 853.10 | 875.10 | +2.42% | +3.06% | +0.96% | +4.26% |
| T-24 | 10 Jan | 876.00 | 878.65 | 863.00 | 871.65 | -0.39% | +2.65% | -0.09% | +4.23% |
| T-23 | 11 Jan | 876.00 | 876.00 | 853.00 | 855.60 | -1.84% | +0.76% | -0.19% | +3.54% |
| T-22 | 12 Jan | 854.95 | 870.00 | 853.25 | 868.60 | +1.52% | +2.29% | -0.40% | +3.45% |
| T-21 | 13 Jan | 868.60 | 872.85 | 863.40 | 870.70 | +0.24% | +2.54% | +0.15% | +3.43% |
| T-20 | 16 Jan | 872.20 | 878.45 | 860.40 | 866.10 | -0.53% | +2.00% | -0.20% | +3.35% |
| T-19 | 17 Jan | 870.70 | 870.70 | 849.35 | 851.95 | -1.63% | +0.33% | +0.69% | +3.26% |
| T-18 | 18 Jan | 850.00 | 883.65 | 848.00 | 875.50 | +2.76% | +3.10% | +1.31% | +3.97% |
| T-17 | 19 Jan | 875.00 | 879.85 | 868.15 | 871.80 | -0.42% | +2.67% | +0.99% | +3.68% |
| T-16 | 20 Jan | 871.80 | 876.15 | 857.95 | 862.10 | -1.11% | +1.53% | +0.55% | +2.92% |
| T-15 | 23 Jan | 859.00 | 876.00 | 859.00 | 871.70 | +1.11% | +2.66% | +1.05% | +3.83% |
| T-14 | 24 Jan | 872.05 | 874.70 | 860.90 | 864.55 | -0.82% | +1.81% | +1.05% | +2.82% |
| T-13 | 25 Jan | 861.50 | 869.30 | 846.00 | 862.40 | -0.25% | +1.56% | -0.21% | +1.56% |
| T-12 | 27 Jan | 860.45 | 866.35 | 844.00 | 851.50 | -1.26% | +0.28% | -1.82% | +2.12% |
| T-11 | 30 Jan | 857.30 | 864.00 | 847.60 | 858.40 | +0.81% | +1.09% | -1.57% | +1.92% |
| T-10 | 31 Jan | 863.30 | 863.30 | 845.00 | 849.85 | -1.00% | +0.08% | -1.49% | +0.91% |
| T-9 | 1 Feb | 848.95 | 860.60 | 848.90 | 853.45 | +0.42% | +0.51% | -1.75% | +0.87% |
| T-8 | 2 Feb | 845.55 | 870.00 | 845.55 | 857.05 | +0.42% | +0.93% | -1.78% | +0.47% |
| T-7 | 3 Feb | 855.00 | 863.50 | 843.85 | 855.80 | -0.15% | +0.78% | -0.42% | -0.52% |
| T-6 | 6 Feb | 855.25 | 862.70 | 850.05 | 859.10 | +0.39% | +1.17% | -0.92% | -0.45% |
| T-5 | 7 Feb | 862.35 | 870.00 | 855.35 | 860.65 | +0.18% | +1.35% | -1.16% | -0.47% |
| T-4 | 8 Feb | 864.50 | 869.00 | 857.30 | 866.35 | +0.66% | +2.03% | -0.32% | +0.89% |
| T-3 | 9 Feb | 873.00 | 889.95 | 868.60 | 876.70 | +1.19% | +3.24% | -0.20% | +0.44% |
| T-2 | 10 Feb | 875.05 | 879.80 | 867.10 | 874.60 | -0.24% | +3.00% | -0.41% | +0.64% |
| T-1 | 13 Feb | 876.00 | 876.00 | 852.00 | 856.55 | -2.06% | +0.87% | -0.89% | +0.16% |
| base | 14 Feb | 852.05 | 860.65 | 824.05 | 849.15 | -0.86% | +0.00% | +0.00% | +0.00% |
| T+1 | 15 Feb result | 841.85 | 852.00 | 835.10 | 843.55 | -0.66% | -0.66% | +0.48% | -0.10% |
| T+2 | 16 Feb | 847.80 | 868.75 | 845.20 | 862.50 | +2.25% | +1.57% | +0.59% | +0.41% |
| T+3 | 17 Feb | 854.00 | 854.00 | 815.00 | 830.90 | -3.66% | -2.15% | +0.08% | -0.77% |
| T+4 | 20 Feb | 825.95 | 844.00 | 819.00 | 832.05 | +0.14% | -2.01% | -0.48% | -1.58% |
| T+5 | 21 Feb | 832.00 | 834.00 | 812.75 | 813.60 | -2.22% | -4.19% | -0.58% | -1.87% |
| T+6 | 22 Feb | 813.25 | 826.55 | 808.00 | 820.05 | +0.79% | -3.43% | -2.09% | -2.10% |
| T+7 | 23 Feb | 820.05 | 825.00 | 808.80 | 819.90 | -0.02% | -3.44% | -2.33% | -2.29% |
| T+8 | 24 Feb | 819.90 | 822.30 | 800.00 | 805.45 | -1.76% | -5.15% | -2.59% | -2.06% |
| T+9 | 27 Feb | 806.00 | 815.00 | 802.45 | 811.35 | +0.73% | -4.45% | -3.00% | -2.83% |
| T+10 | 28 Feb | 806.10 | 818.10 | 805.00 | 807.95 | -0.42% | -4.85% | -3.49% | -4.10% |
| T+11 | 1 Mar | 810.35 | 811.20 | 801.05 | 807.70 | -0.03% | -4.88% | -2.67% | -3.95% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.